Skip to main content

Peer Review reports

From: Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study

Original Submission
17 Oct 2023 Submitted Original manuscript
27 Nov 2023 Reviewed Reviewer Report
4 Dec 2023 Reviewed Reviewer Report
24 Feb 2024 Author responded Author comments - Cheng Wang
Resubmission - Version 2
24 Feb 2024 Submitted Manuscript version 2
28 Feb 2024 Reviewed Reviewer Report
28 Feb 2024 Reviewed Reviewer Report
31 Mar 2024 Author responded Author comments - Cheng Wang
Resubmission - Version 3
31 Mar 2024 Submitted Manuscript version 3
4 Apr 2024 Reviewed Reviewer Report
29 May 2024 Author responded Author comments - Cheng Wang
Resubmission - Version 4
29 May 2024 Submitted Manuscript version 4
5 Jun 2024 Author responded Author comments - Cheng Wang
Resubmission - Version 5
5 Jun 2024 Submitted Manuscript version 5
Publishing
10 Jun 2024 Editorially accepted
18 Jun 2024 Article published 10.1186/s12916-024-03474-0

You can find further information about peer review here.

Back to article page